English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Corteva updates expectations for third quarter and full year 2023qrcode

Oct. 30, 2023

Favorites Print
Forward
Oct. 30, 2023

Corteva, Inc. (NYSE: CTVA) has provided preliminary net sales and earnings results for the quarter ended September 2023 and an update for its expectations for full year 2023 net sales and earnings. Third quarter net sales are expected to be approximately $2.6 billion. Third quarter GAAP income and earnings per share (EPS) from continuing operations are expected to be a loss of approximately $315 million and $0.45 per share, respectively. Operating EBITDA1 is expected to be approximately $18 million for the period, with Operating EPS1 expected to be a loss of approximately $0.23 per share.


Management lowered the Company's full year 2023 net sales and earnings guidance2 in light of evolving market dynamics in Brazil, including:


  • Significant delay in orders due to just-in-time farmer purchases on both plantings and crop protection applications

  • Tighter Brazilian farmer margins largely driven by macro factors, including inflation, interest and exchange rates, and record production during the 2022/2023 crop season

  • Ongoing channel inventory destocking in Brazil crop chemicals

  • Pricing and volume pressures in crop chemicals associated with elevated generic imports

  • Lower fourth quarter seed deliveries impacted by lower Summer corn planted area and potentially delayed and reduced Safrinha planted area for the 2023/2024 crop season


"Third quarter results and the performance of our operations were broadly aligned with expectations around the globe. However, early fourth quarter indicators from Brazil have caused us to recalibrate sales and earnings estimates in both Seed and Crop Protection for the remainder of the year given the significance of Brazil to our fourth quarter business. The change in order patterns and planted area intentions, together with additional Crop Protection volume and pricing pressures in Brazil, is now included in our updated guidance," said Chuck Magro, Corteva Chief Executive Officer.


"I am pleased with the EBITDA margin improvement we've delivered so far this year through strong pricing, product mix improvement, as well as productivity and cost actions," continued Magro. "We will discuss early views on our 2024 outlook on our third quarter earnings call on November 9th. Meanwhile, we remain committed to $750 million of share repurchases in 2023."


Full year net sales are now expected to be in the range of $17.0 billion and $17.3 billion, with Operating EBITDA expected to be in the range of $3.25 billion and $3.45 billion. Full year 2023 Operating EPS is now expected to be in the range of $2.50 and $2.70 per share.


The Company is not able to reconcile its forward-looking non-GAAP financial measures to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of its control, such as Significant Items, without unreasonable effort.


The select financial information provided in this release is preliminary. As the Company completes its third quarter financial close process and finalizes its outlook for the remainder of the year, it is possible that the Company may identify items that require it to make adjustments to the preliminary financial information set forth above, and those adjustments could be material. Furthermore, this update does not present all necessary information for an understanding of the Company's financial condition as of the date of this release, or its results of operations for the third quarter of 2023.


Corteva will release its third quarter 2023 earnings on Wednesday, November 8, after the stock market close via PR Newswire and its website. The Company will host a live webcast of its third quarter 2023 earnings conference call on Thursday, November 9, 2023, at 9:00 a.m. Eastern Time.


1. Operating EPS and Operating EBITDA are non-GAAP measures. See page A-1 for further discussion. 2. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See page 3 for further discussion.


0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox